Struggling to find Quviviq at your pharmacy? Learn why this insomnia medication is hard to find in 2026 and what you can do to get your prescription filled.
You finally got a prescription for Quviviq (Daridorexant) — a newer insomnia medication that works differently from older sleep aids — only to hear your pharmacist say those dreaded words: "We don't have it in stock."
If this sounds familiar, you're far from alone. Patients across the country have been reporting difficulty finding Quviviq at their local pharmacies. In this post, we'll explain what Quviviq is, why it's so hard to find, and most importantly, what you can do about it.
Quviviq is the brand name for Daridorexant, a prescription medication approved by the FDA in January 2022 for the treatment of insomnia in adults. It helps people who have trouble falling asleep, staying asleep, or both.
Unlike older sleep medications like Ambien (Zolpidem) or Lunesta (Eszopiclone), which work by enhancing the brain's GABA system to sedate you, Quviviq belongs to a newer class of drugs called dual orexin receptor antagonists (DORAs). Instead of sedating you, it blocks orexin — a brain chemical that keeps you awake — allowing your body to transition into sleep more naturally.
Quviviq is available as a 25 mg or 50 mg tablet, taken once nightly within 30 minutes of bedtime. It's a Schedule IV controlled substance, meaning it has a low but recognized potential for misuse. You can learn more in our detailed guide: What Is Quviviq? Uses, Dosage, and What You Need to Know.
There are several reasons why you might be having trouble getting your hands on Quviviq in 2026. Let's break them down.
Quviviq was only approved in 2022 and became available in pharmacies in May of that year. As of 2026, there is no generic version of Daridorexant. The active patents on Quviviq extend through 2034, which means a generic isn't expected anytime soon.
Because it's brand-name only, many pharmacies — especially large chain pharmacies — may not keep it routinely stocked. Pharmacies tend to stock medications based on demand, and newer, less commonly prescribed drugs often don't make the cut for regular inventory.
Without insurance, a 30-day supply of Quviviq can cost between $550 and $680. That's a significant price tag that limits how many patients end up filling the prescription. When demand at any single pharmacy location is low, the pharmacy may not keep it on the shelf.
Even with insurance, many plans place Quviviq on a higher formulary tier or require prior authorization, which creates friction and delays. Some plans also require step therapy — meaning you need to try other sleep medications first before Quviviq is covered. For tips on reducing the cost, check out our guide on how to save money on Quviviq.
Prior authorization requirements mean your doctor's office has to submit paperwork to your insurance company before the prescription can be filled. This process can take days or even weeks. During that time, you're stuck waiting — and the pharmacy may not hold stock for a prescription that hasn't been approved yet.
Step therapy requirements add another layer of delay. If your insurance insists you try Belsomra (Suvorexant) or Dayvigo (Lemborexant) before covering Quviviq, you could be waiting months to get the medication your doctor originally prescribed.
As a Schedule IV controlled substance, Quviviq is subject to stricter ordering and dispensing rules than non-controlled medications. Pharmacies must follow DEA regulations for controlled substance inventory, which can limit how freely they order and stock it.
The good news is that Quviviq is not in a formal shortage. It's manufactured and available — the challenge is finding a pharmacy near you that has it on hand. Here's what you can do:
Medfinder lets you search for pharmacies that currently have Quviviq in stock near your location. Instead of calling pharmacy after pharmacy, you can check availability in seconds. It's free and designed specifically for hard-to-find medications.
Independent pharmacies are often more willing and able to order specialty or less common medications than large chain pharmacies. They may also be able to special-order Quviviq for you within a day or two. Don't overlook your local independent pharmacy — they can be a lifeline for hard-to-find drugs.
Idorsia, the manufacturer of Quviviq, offers a support program called QUVIVIQ360 that can help with prescription fulfillment. The program works with vitaCare and ConnectiveRx to help get your prescription to a pharmacy that can fill it. Your doctor's office can help you enroll.
Some insurance plans offer mail-order pharmacy options that can deliver Quviviq directly to your home. This can bypass the issue of local pharmacy stocking entirely. Check with your insurance plan to see if mail-order is available for controlled substances.
For a full step-by-step guide, read our post on how to find Quviviq in stock near you.
If you've tried everything and still can't get Quviviq, talk to your doctor about alternatives. The two other FDA-approved dual orexin receptor antagonists — Belsomra (Suvorexant) and Dayvigo (Lemborexant) — work through a similar mechanism. Older options like Ambien and Lunesta are also available and have generics, making them easier to find and more affordable.
We cover all of these in detail in our post on alternatives to Quviviq.
Quviviq is a genuinely innovative insomnia treatment, but being new, expensive, and brand-name only means it can be frustrating to find. The key is to be proactive: use tools like Medfinder, work with your doctor and pharmacist, and explore manufacturer support programs. Getting a good night's sleep shouldn't require a treasure hunt — but with the right approach, you can find Quviviq and get the rest you deserve.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
